Biomedical applications with emphasis on the design of smart materials, specifically
magnetic nanoparticles (MNPs) are considered to have technological benefits because they …

High-quality point-of-care is critical for timely decision of disease diagnosis and healthcare
management. In this regard, biosensors have revolutionized the field of rapid testing and …

Rapid and inexpensive immunodiagnostic assays to monitor severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) seroconversion are essential for conducting large …

The COVID-19 pandemic caused by the SARS-CoV-2, a ribonucleic acid (RNA) virus that
emerged less than two years ago but has caused nearly 6.1 million deaths to date. Recently …

In recent decades, the use of engineered nanoparticles has been increasing in various
sectors, including biomedicine, diagnosis, water treatment, and environmental remediation …

The effect of the on-going COVID-19 pandemic on global healthcare systems has
underlined the importance of timely and cost-effective point-of-care diagnosis of viruses. The …

Magnetic nanoparticles (MNPs) have been adapted for many applications, eg, bioassays for
the detection of biomarkers such as antibodies, by controlled engineering of specific surface …

The recent decade has witnessed a remarkable surge in the field of nanoparticles, from their
synthesis, characterization, and functionalization to diverse applications. At the nanoscale …

With the ongoing global pandemic of coronavirus disease 2019 (COVID-19), there is an
increasing quest for more accessible, easy-to-use, rapid, inexpensive, and high-accuracy …

The novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) emerged at the
end of 2019, resulting in the ongoing COVID-19 pandemic. The high transmissibility of the …